CLINICAL_TRIALS
trial_result
· 2019-11-05
Clinical Trial Update: Detecting an Early Response to Donepezil With Measures of Visual Attention [Phase 4]
Summary
Phase 4 trial updating on detecting early response to donepezil using measures of visual attention in Alzheimer disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Alzheimer Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-11-05